Low Level Light Therapy in the Treatment of Meibomian Gland Dysfunction

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00020140

Enrollment

Registered

2019-12-04

Start date

2019-11-12

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Meibomian Gland Dysfunction H02.8

Interventions

Group 1: Moderate Meibomian Gland (MGD). Assessment of the effect of the LLLT mask (Espanione Group, Italy) on the tear film and lids in meibomian dysfunction. in MGD pateints. Before and after treat

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Moderate Meibomian Gland Dysfunction

Exclusion criteria

Exclusion criteria: Photosensitivity (skin / eye), epileptics, pregnant, Acute inflammation of the eye, eye surgery less than 1 year

Design outcomes

Primary

Measure	Time frame
Tear film stability, non-invasive. Measured before and after treatment	—

Secondary

Measure	Time frame
Dry eye symptoms Evaluated before and after treatment using a visual analogue score	—

Countries

Germany

Contacts

Public ContactHeiko Pult

ovr@heiko-pult.de01749025090

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026